You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD25

Showing 26 - 50 of 9,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft Vs Host Disease Trial in Beijing (UC-MSC, Anti-CD25 mAb)

Not yet recruiting
  • Graft Vs Host Disease
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Feb 1, 2021

Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage IB Breast Cancer AJCC v8
  • +16 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Sargramostim
  • Seattle, Washington
  • +1 more
Jul 27, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
  • +10 more
Feb 12, 2020

Acne Vulgaris Trial in United States (CD5789 25 µg/g cream, CD5789 50 µg/g cream, CD5789 100 µg/g cream)

Completed
Has Results
  • Acne Vulgaris
  • CD5789 25 µg/g cream
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 23, 2021

Immunosuppressive Treatment of Living-donor Renal Transplantation Trial in Berlin (autologous CD4+CD25+FoxP3+ natural regulat. T

Completed
  • Immunosuppressive Treatment of Living-donor Renal Transplantation
  • autologous CD4+CD25+FoxP3+ natural regulat. T cells (nTregs)
  • Berlin, Germany
    Charité University Medicine, Dept. of Nephrology and Internal In
Feb 3, 2020

Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)

Unknown status
  • Extranodal NK/T-cell Lymphoma
  • (no location specified)
Apr 6, 2020

Rosacea Trial in Canada, United States (CD07805/47 Gel, Placebo)

Completed
Has Results
  • Rosacea
  • CD07805/47 Gel
  • Placebo
  • Hot Springs, Arkansas
  • +14 more
Feb 16, 2021

Adult T Cell Leukemia, Adult T Cell Lymphoma Trial in Bronx (IMTOX-25)

Completed
  • Adult T Cell Leukemia
  • Adult T Cell Lymphoma
  • Bronx, New York
  • +6 more
Sep 4, 2019

Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in San Francisco (Ex vivo

Terminated
Has Results
  • Lupus Erythematosus, Cutaneous
  • +2 more
  • Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
  • San Francisco, California
    University of California, San Francisco
Oct 22, 2019

Other Trial in Québec (DopaSnap®, RDL of CD-LD)

Completed
  • Other
  • Québec, Montreal, Canada
    Syneous Health
Jan 21, 2020

Transplant Failure Trial in Marseille (BLOOD SAMPLE ANALYSIS)

Recruiting
  • Transplant Failure
  • BLOOD SAMPLE ANALYSIS
  • Marseille, Paca, France
    Assistance Publique Des Hopitaux de Marseille
Oct 28, 2021

Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

Active, not recruiting
Has Results
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 13, 2022

Ulcerative Colitis (Disorder) Trial in Atlanta, New York (Hydroxychloroquine, Mesalamine)

Recruiting
  • Ulcerative Colitis (Disorder)
  • Atlanta, Georgia
  • +1 more
Sep 26, 2022

Role of Inflammatory Markers in Sepsis

Not yet recruiting
  • Diagnostic
  • Serology tests
  • Cairo, Egypt
    Walaa Y Elsabeeny
Oct 26, 2023

Pediatric Induction Therapy in Kidney Transplantation

Completed
  • Kidney Transplant Rejection
  • Pediatric Kidney Disease
  • Basiliximab Injection
  • rabbit ATG
  • Guangzhou, Guangdong, China
  • +4 more
Oct 15, 2023

Colorectal Cancer, Colorectal Tumors Malignant, Intestinal Tumors, Malignant Trial in Shanghai (Ileostomy, Transverse colostomy)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Ileostomy
  • Transverse colostomy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 2, 2023

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    Guillain-Barré Syndrome Trial (CK0801)

    Withdrawn
    • Guillain-Barré Syndrome
    • CK0801
    • (no location specified)
    Jan 3, 2023

    Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)

    Recruiting
    • Allergy
    • SQ tree SLIT-tablet
    • Placebo
    • Vienna, Austria
    • +83 more
    Dec 21, 2022

    Vitamin d Deficiency Trial in Nîmes (Vitamin D, Placebo)

    Not yet recruiting
    • Vitamin d Deficiency
    • Vitamin D
    • Placebo
    • Nîmes, France
      CHU de Nîmes
    Dec 8, 2022

    Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Belantamab Mafodotin)

    Not yet recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • Fayetteville, Arkansas
    • +75 more
    Aug 11, 2022

    Melanoma Trial in Portland (PBMC re-infusion, CD25 depletion)

    Terminated
    • Melanoma
    • PBMC re-infusion
    • CD25 depletion
    • Portland, Oregon
      Providence Portland Medical Center
    Aug 27, 2018

    Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

    Not yet recruiting
    • Metastatic Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 19, 2023

    Cancer Trial in Genova (Short-term modified fasting)

    Recruiting
    • Cancer
    • Short-term modified fasting
    • Genova, Italy
      San Martino Hospital
    Feb 17, 2023

    Nutrition, Healthy Trial in Taichung (Sinphar Lipucan Capsule)

    Recruiting
    • Nutrition, Healthy
    • Sinphar Lipucan Capsule
    • Taichung, Please Select, Taiwan
      Asia University
    Nov 13, 2022